HR-Positive Metastatic Breast Cancer — An Interview with Dr Seth Wander on Optimizing Biomarker Assessment and Related Treatment Decision-Making
Dr Seth Wander from Massachusetts General Hospital in Boston discusses the role of biomarker assessment in the management of HR-positive metastatic breast cancer.
CME information and select publications here.
You May Also Like
Pädagogik&Pinot
Fea Finger & Sarah Bauer
The Grave Talks | Haunted, Paranormal & Supernatural
Ghost Stores, Haunted, Paranormal & Supernatural Stories
Podcast de Juan Ramón Rallo
Juan Ramón Rallo
Eye On The Sky
Vermont Public
The Dissenter
Ricardo Lopes
The Feldman Protocol
Dave Feldman
La Science, CQFD
France Culture
Kvantum ideí
Kvantum ideí
Vida Eterna. Respuestas desde la Ciencia | Dr. Manuel Sans Segarra
Dr. Manuel Sans Segarra
Trent Loos Podcast
Trent Loos
Pädagogik&Pinot
Fea Finger & Sarah Bauer
The Grave Talks | Haunted, Paranormal & Supernatural
Ghost Stores, Haunted, Paranormal & Supernatural Stories
Podcast de Juan Ramón Rallo
Juan Ramón Rallo
Eye On The Sky
Vermont Public
The Dissenter
Ricardo Lopes
The Feldman Protocol
Dave Feldman
La Science, CQFD
France Culture
Kvantum ideí
Kvantum ideí
Vida Eterna. Respuestas desde la Ciencia | Dr. Manuel Sans Segarra
Dr. Manuel Sans Segarra
Trent Loos Podcast
Trent Loos
Community discussion